NCT00446563
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
See it on ClinicalTrials.gov ↗90 people
27.8%
72.2%
25 womenmiddle line = equal numbers65 men
- Phase
- PHASE3
- Paid for by
- Novartis
- Finished
- 2010-03
- Health conditions
- Hypertension; Hypertrophy, Left Ventricular
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 57.7 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Symptomatic heart failure”
- No diabetes
Women with diabetes were turned away.
“Insulin-dependent diabetes mellitus or poorly controlled diabetes mellitus.”
Study titles and rules are shown in their original English.